Cervical cancer is one of the most common gynecological malignancies, and its incidence rate is second only to breast cancer, seriously threatening women’s life and health. In recent years, many countries and regions, including our scholars, have reported a trend of younger cervical cancer incidence, with younger cervical cancer patients accounting for 15%-20% of cervical cancer patients in the same period. Most scholars now refer to cervical cancer patients aged ≤35 years as young cervical cancer and cervical cancer patients >35 years as old cervical cancer. Combined treatment based on surgery and radiotherapy has a much greater impact on the quality of survival and physiological function of young cervical cancer patients than other age cervical cancers. Surgery is currently the main treatment method for young cervical cancer. With the trend of younger cervical cancer incidence and people’s demand for better quality of life, the treatment for young cervical cancer patients should not only aim at complete surgery, tumor non-recurrence and prolonged survival, but also maximize the quality of survival on the basis of ensuring prognosis. Young cervical cancer patients often have higher requirements for the preservation of female physiological and endocrine functions. With the increase of the age of first pregnancy, many young cervical cancer patients did not have children at the time of the disease and hope to preserve reproductive functions. Medically induced menopause will produce more severe perimenopausal symptoms. Therefore, when treating young cervical cancer patients, we should take into account the principles of humanization and individualization while following the standardized treatment, and make treatment decisions together with patients while fully informing them and their families of the pros and cons of treatment options, so as to achieve the most optimal treatment. At present, the problems in pathological diagnosis and clinical staging of young cervical cancer patients lead to over and under treatment as follows: 1. A few hospitals only diagnose cervical carcinoma in situ or early cervical invasive carcinoma through multi-point biopsy of the cervix. Thus, total hysterectomy or radical hysterectomy or radical total hysterectomy is performed, resulting in inadequate surgical scope or over-treatment. 2.Insufficient clinical experience: mistaking inflammation as cancer infiltration or vice versa during gynecological examination, resulting in excessive and insufficient surgical treatment. Usually, nodule-like thickening of the main ligament suggests parametrial infiltration, while history of pelvic inflammatory disease with thickening of the parametrial ligament suggests parametrial inflammatory changes. 3.Insufficient attention is paid to young women in census: young cervical cancer is mostly of celiac type in early stage, so it is easy to be misdiagnosed as cervicitis if lack of vigilance. Cervical scraping cytology and HPV examination or cervical biopsy should be performed first to exclude the possibility of cervical cancer so as to avoid misdiagnosis and mistreatment. In some patients, due to the importance of cervical inflammation, microwave and laser treatments are actively used to treat the surface of the cervix without ruling out malignancy, which makes the symptoms disappear within a short period of time and the course of the disease more insidious, and also makes the early lesions originally confined to the cervical area further infiltrate and spread due to the irritation of physical factors, and develop into infiltrative or intermediate or advanced types, making the subsequent treatment more difficult. This makes subsequent treatment more difficult. In conclusion, although there are still many shortcomings and transitional treatments for young cervical cancer patients in recent years, with the improvement of surgical skills and procedures as well as chemoradiotherapy and other techniques, and with the renewal of medical philosophy, doctors must make the best decisions based on the best evidence of evidence-based medicine, combined with the specific conditions of patients, to make the best decisions of standardization and individualization, while maximizing the life of young patients. maximize the quality of survival of young cervical cancer patients.